Josh Gottheimer's stock trades, scored
Representative Josh Gottheimer of New Jersey has one of the largest trading records in Congress. His filings disclose 2,843 transactions, and 696 of them are purchases of common stock that can be priced and scored — more than almost any other member Hillscore tracks. He ranks 32 of 60, with a Composite of +14.5%: the plain average return of every disclosed buy in the last five years.
The scored record runs from 6 December 2021 to 6 August 2026. Every trade, with its price and outcome, is on his page.
Why a big record matters
Most rankings of congressional traders are topped by members with a handful of trades, where one lucky pick moves the average. A record this size is the opposite: no single trade can carry it. Whatever Gottheimer's numbers say, they say it with unusual weight.
What he bought
Technology is his largest sector, at 33.4% of purchases, and 39.5% of his buys were mega-caps. The stocks he bought most often were Tesla (24), Eli Lilly and Company (18), Apple (16), Microsoft (14), Advanced Micro Devices (11). Repeated buys of the same stock count separately: each one is a decision, so each one is scored.
How it did against the sector
A raw return credits a trader with whatever the market did. The fairer test is the stock against its own sector over the same three months — did the pick beat simply owning the sector?
Across 662 of his buys old enough to measure, the stock moved +3.05% in the following three months, and −0.42% against its sector. 47.0% of his picks beat their sector over that window. Taken together, his picks finished behind the sector funds they sit in — close to what owning the sectors would have done. That is the typical result across Congress: the full comparison.
Committee overlap
171 of his measured buys were Notable: in a sector one of his own committees oversees. Those came to −4.85% against their sectors, against +1.12% for the rest — 6.0 points behind his other buys. On a sample this size that is a real difference, and it runs against the usual suspicion: if committee access gave an edge, it would show up here. A Notable flag is a screening signal, not an accusation: what it means.
Best and worst calls
Measured three months after purchase, against the sector:
- Best: Tandem Diabetes Care (TNDM), bought 22 September 2025: +78.1% raw, +64.4% against its sector.
- Worst: Fabrinet (FN), bought 1 May 2026: −38.4% raw, −46.7% against its sector.
Across 662 measured buys, neither end tells you much. The average is the record.
What the record cannot show
Filings give a date and a dollar band, never the price paid, so every figure uses that day's close. Trades by a spouse or in managed accounts are filed under the member's name. And the scores cover purchases only: a well-timed sale earns nothing here. How the scoring works.
For how he compares with everyone else, see the best and worst traders in Congress.